A lawsuit filed in mid-July seeks compensation and damages for 18 patients who claim that Merck’s anti-shingles vaccine Zostavax actually gave them the condition they were seeking to avoid. Hailing from a variety of states, the plaintiffs have come together to sue Merck in its home state of New Jersey.
Zostavax is targeted at people aged 50 years or older and the CDC has gone so far as to ...
continue reading...